# Jiangsu Cancer Hospital

Source: https://onco.cc/institutions/jiangsu-cancer-hospital/  
OnCo record `jiangsu-cancer-hospital` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Jiangsu Cancer Hospital in Nanjing is a large provincial cancer centre and a frequent lead site for Chinese oesophageal, lung and gastric cancer trials.

## Summary

Jiangsu Cancer Hospital in Nanjing, also known as the Jiangsu Institute of Cancer Research and the Affiliated Cancer Hospital of Nanjing Medical University, is a large provincial cancer centre and a frequent lead site for Chinese oesophageal, lung and gastric cancer trials. It has high oesophageal and lung cancer volumes, hosts domestic PD-1, antibody-drug conjugate and radiotherapy trials, and runs the province's screening programmes in one of China's oesophageal cancer high-incidence regions. OnCo connects it to oesophageal cancer, non-small-cell lung cancer and gastric cancer. How much of its trial activity produces evidence that regulators outside China accept is the open question for centres of this kind. Its oesophageal, thoracic and screening programmes are listed below.

## Fields

- Kind: Institution
- Last checked: 2026-09-10
- Also known as: Jiangsu Institute of Cancer Research; Affiliated Cancer Hospital of Nanjing Medical University; 江苏省肿瘤医院
- Tags: china
- City: Nanjing, CN
- Type: cancer-center
- Website: https://www.jszlyy.com.cn/

## Sources

- Official website: https://www.jszlyy.com.cn/

## Connected records

- cancers: [Gastric & gastro-oesophageal junction cancer](https://onco.cc/cancers/gastric/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Oesophageal cancer](https://onco.cc/cancers/esophageal/)

---
JSON: https://onco.cc/api/v1/entities/jiangsu-cancer-hospital.json